- Veterinary opioids, which are critical for managing pain and providing anesthesia in animals, have become increasingly essential in modern veterinary medicine due to their effectiveness, controlled dosing, and growing demand for animal welfare in both companion and livestock animal care
- The escalating demand for veterinary opioids is primarily driven by the rising prevalence of chronic and post-operative pain in animals, increasing pet ownership, higher spending on animal healthcare, and advancements in veterinary surgical procedures
- North America dominated the veterinary opioids market with the largest revenue share of 41.3% in 2024, supported by a well-established veterinary healthcare infrastructure, higher awareness of animal pain management, and favorable regulatory frameworks. The U.S. led the region with a high adoption rate of veterinary opioid formulations in both small and large animal practices
- Asia-Pacific is expected to be the fastest-growing region in the veterinary opioids market during the forecast period, with a projected CAGR of 7.9% from 2025 to 2032, due to rising animal healthcare expenditure, growing livestock population, and expanding veterinary service access in emerging economies such as China and India
- Synthetic opioids segment dominated the veterinary opioids market with a market share of 47.6% in 2024, driven by the widespread use of agents such as fentanyl and tramadol for their potency, safety profile, and versatility in various animal procedures
